Alector, Inc. ALEC
2.63 USD +0.10 (+3.95%)
At closeNov 11, 2026, 7:46 PM EST
2.64 +0.01 +0.38%
After hours · Nov 11, 7:46 PM ET
2.54 Day range 2.84
1.09 52-week range 2.84
- YTD
- +68.59%
- 1 year
- +93.38%
News
zacks.com Are Medical Stocks Lagging Alector (ALEC) This Year? Here is how Alector (ALEC) and CVS Health (CVS) have performed compared to their sector so far this year.
zacks.com Earnings Estimates Rising for Alector (ALEC): Will It Gain? Alector (ALEC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
benzinga.com Alector Q3 EPS $1.11 Beats $(0.23) Estimate, Sales $162.866M Beat $2.678M Estimate Alector (NASDAQ:ALEC) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $(0.23) by 582.61 percent. This is a 426.47 percent increase over losses of $(0.34)…
globenewswire.com Alector Reports Third Quarter 2026 Financial Results and Provides Business Update Advancing a pipeline built entirely on the Alector Brain Carrier (ABC) blood-brain barrier platform, spanning antibody, enzyme, and siRNA programs, with AL137, Alector's lead ABC-enabled anti-amyloid…
zacks.com Will Alector (ALEC) Report Negative Q3 Earnings? What You Should Know Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
globenewswire.com Alector Announces Pricing of Underwritten Offering SOUTH SAN FRANCISCO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (“Alector,” Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating…- benzinga.com Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8 HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8 HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
seekingalpha.com Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript
marketbeat.com Alector Maps Brain-Delivery Pipeline for Alzheimer's, Parkinson's Therapies Alector NASDAQ: ALEC outlined its strategy to advance brain-penetrant therapies for neurodegenerative diseases, highlighting an anti-amyloid beta antibody for Alzheimer's disease and two siRNA…
globenewswire.com Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline Agenda to feature progress for AL137, its lead anti-amyloid beta antibody; AL164, its tau siRNA program; and AL062, its alpha-synuclein siRNA program
benzinga.com Morgan Stanley Maintains Underweight on Alector, Raises Price Target to $3 Morgan Stanley analyst Sean Laaman maintains Alector (NASDAQ:ALEC) with a Underweight and raises the price target from $2 to $3.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector…
benzinga.com Alector Teams Up With Genentech On Potential Parkinson’s Treatment Alector, Inc. (NASDAQ:ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced it has entered into an exclusive…
globenewswire.com Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson's Disease and Other Neurodegenerative Diseases Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled by Alector Brain Carrier (ABC), Alector's proprietary…
defenseworld.net Contrasting Alector (NASDAQ:ALEC) & Ionis Pharmaceuticals (NASDAQ:IONS) Alector (NASDAQ: ALEC - Get Free Report) and Ionis Pharmaceuticals (NASDAQ: IONS - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies…
benzinga.com Alpha Buying: Follow the Money From NVIDIA and Merck Wall Street loves a good upgrade, especially when the stock has already doubled and the analyst can explain why everyone should have owned it six months ago. One place I look for ideas is the…
seekingalpha.com Alector, Inc. (ALEC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Alector, Inc. (ALEC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com Alector, Inc. (ALEC) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Prepared Remarks Transcript Alector, Inc. (ALEC) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Prepared Remarks Transcript
defenseworld.net Comparing Alector (NASDAQ:ALEC) and Sarepta Therapeutics (NASDAQ:SRPT) Alector (NASDAQ: ALEC - Get Free Report) and Sarepta Therapeutics (NASDAQ: SRPT - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…
globenewswire.com Alector to Participate in Upcoming Healthcare Conferences SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares…
zacks.com Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.3 per share a year ago.
globenewswire.com Alector Reports Second Quarter 2026 Financial Results and Provides Business Update Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector's lead ABC-enabled anti-amyloid beta (Aβ) antibody…
benzinga.com GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company moves to end its collaboration with Alector.
reuters.com Alector and GSK partnership to end after dementia, Alzheimer's drug failures Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental antibody drugs after both the drug candidates suffered clinical setbacks.
zacks.com Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.41 per share a year ago.
benzinga.com Alector Launches Up To $125M At-The-Market Common Stock Offering Through TD Cowen $125,000,000Common StockWe have entered into a sales agreement with TD Securities (USA) LLC ("TD Cowen") relating to shares of our common stock offered by this prospectus supplement and the…- benzinga.com Alector Q1 EPS $(0.21) Beats $(0.35) Estimate, Sales $1.046M Miss $6.207M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40 percent. This is a 48.78 percent increase over losses of $(0.41) per…
globenewswire.com Alector Reports First Quarter 2026 Financial Results and Provides Business Update Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody…
zacks.com Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
benzinga.com This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Wall Street analysts upgraded CRWD, ALEC, RIVN, SEDG, and DNTH. See what other analysts say about these stocks. Consider buying CRWD.
benzinga.com Alector Q4 Earnings Assessment - benzinga.com Alector Q4 EPS $(0.34) Beats $(0.39) Estimate, Sales $6.237M Beat $2.672M Estimate Alector (NASDAQ:ALEC) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 13.71 percent. This is a 1600 percent decrease over losses of $(0.02) per…
benzinga.com Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.- benzinga.com HC Wainwright & Co. Maintains Buy on Alector, Lowers Price Target to $5 HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $10 to $5.
benzinga.com Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings 
benzinga.com Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket 
benzinga.com AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Alector Discontinues Open-Label Extension For Latozinemab; Co To Reduce Workforce By About 49% Alector Pipeline OutlookAlector remains focused on advancing a pipeline of programs designed to treat neurodegenerative diseases through mechanisms that remove toxic proteins, replace deficient…
benzinga.com 4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals 4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.